Showing results (191-200 of 498) with videos related to

Sort By:
Pageof 50
Haematologica|February 16, 2005
Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosisVincent Lévy, Pierre Morel, Raphaël Porcher, et al.
Biochimica Et Biophysica Acta|January 11, 2011
A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serumFrancesca Lavatelli, Francesca Brambilla, Veronica Valentini, et al.
Leukemia & Lymphoma|August 27, 2021
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosisGiovanni Palladini, Simone Celant, Paolo Milani, et al.
Circulation. Heart Failure|March 25, 2022
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working GroupMathew S Maurer, Preston Dunnmon, Mariana Fontana, et al.
Clinical Chemistry|October 7, 2010
Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassayIngrid Zegers, Thomas Keller, Wiebke Schreiber, et al.
Hematology (Amsterdam, Netherlands)|November 15, 2013
The red cell distribution width (RDW): value and role in preterm, IUGR (intrauterine growth restricted), full-term infantsFrancesca Garofoli, Laura Ciardelli, Iolanda Mazzucchelli, et al.
Molecular Immunology|October 24, 2007
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulinsValentina Navazza, Silvia Gabba, Andrea Alfieri, et al.
Annals of Hematology|August 10, 2011
Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosisRiccardo Caccialanza, Giovanni Palladini, Catherine Klersy, et al.
Blood|August 14, 2014
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosisGiovanni Palladini, Ute Hegenbart, Paolo Milani, et al.
Pageof 50